Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting by Jingyi Yang, Hao Guo, Lu Han, Yongping Song, Keshu Zhou

Get full text

Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms by Hao Guo, Jingyi Yang, Haoran Wang, Xingchen Liu, Yanyan Liu, Keshu Zhou

Get full text

Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect by Haoran Wang, Hao Guo, Jingyi Yang, Yanyan Liu, Xingchen Liu, Qing Zhang, Keshu Zhou

Get full text

Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer by Jing Ding, Deyu Li, Xingchen Liu, Hu Hei, Baoxi Sun, Dongmin Zhou, Keshu Zhou, Yongping Song

Get full text

PB1929: EFFICACY AND SAFETY OF ACALABRUTINIB IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: AN OPEN-LABEL, MULTICENTER PHASE 1/2 TRIAL by Shenmiao Yang, Haiwen Huang, Keshu Zhou, Xielan Zhao, Yan-Qiu Han#, Lindong LI, Anna Butturini, Yiqiu Wang, Xiaofeng Liu, Peiqiong Lai, Jianyong LI

Get full text

Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph+ B cell acute lymphoblastic leukemia by Lu Han, Ran Zhao, Jingyi Yang, Yingling Zu, Yanyan Liu, Jian Zhou, Linlin Li, Zhenghua Huang, Jishuai Zhang, Quanli Gao, Yongping Song, Keshu Zhou

Get full text

Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies by Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song, Quanli Gao

Get full text

Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma by Zhen Li, Binglei Zhang, Xinxin Fan, Ruirui Gui, Fengkuan Yu, Juan Wang, Yanli Zhang, Keshu Zhou, Yanyan Liu, Yufu Li, Jing Ding, Yongping Song, Jian Zhou

Get full text

Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus by Jian Zhou, Lu Han, Keshu Zhou, Baijun Fang, Linlin Li, Quanli Gao, Hu Zhou, Yongping Song, Qingsong Yin, Xinghu Zhu, Lingdi Zhao, Xudong Wei, Bengling Xu, Jishuai Zhang

Get full text

P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA by Huilai Zhang, Ying Cheng, Hai-Yan Yang, Liling Zhang, Liqun Zou, Ye Guo, Junning Cao, Huiqiang Huang, Zhao Wang, Sha Huang, Zhiyu Liang, Jiaoyan Lyu, Yiqian Fang, Aileen Cohen, Keshu Zhou

Get full text

P626: A PHASE 1 STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF BCL-2 INHIBITOR BGB-11417 IN ADULT PATIENTS WITH MATURE B-CELL MA... by Caixia LI, Jia Wei, Liu Peng, He Huang, Fei LI, Yujun Dong, Qingqing Cai, Shenmiao Yang, Xinyou Zhang, Hui Zhou, Lu Zhang, Zaixing Shi, Zhiyu Liang, Binghao Wu, Keshu Zhou, Depei Wu

Get full text

A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transpl... by Zhenghua Huang, Zhen Li, Juan Wang, Ruirui Gui, Yingling Zu, Fengkuan Yu, Quande Lin, Huifang Zhao, Yanli Zhang, Baijun Fang, Yanyan Liu, Keshu Zhou, Yufu Li, Yuewen Fu, Zhihua Yao, Yongping Song, Jian Zhou

Get full text

P1203: EFFICACY AND SAFETY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) FOR THE TREATMENT OF RELAPSE/REFRACTORY NON-HODGKIN LYMPHOMA: FIRST REAL-WORLD DATA IN CHINESE POPULATION by LI Wang, Yuhua LI, Dehui Zou, Xiaojian Zhu, Dongmei Ji, Wenbin Qian, Ying Lu, Chunyan Ji, Keshu Zhou, Hongmei Jing, Hua Yang, Lanfang LI, Fei LI, Kailin Xu, Ting Niu, Depei Wu, Yu Hu, Wei-LI Zhao

Get full text

Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis by Yuqin Song, Keshu Zhou, Dehui Zou, Dengju Li, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Cheng Fang, Shaohui Sun, Jun Zhu

Get full text

Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials by Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Zhiyue Huang, Huafei Lu, Yuqin Song, Yongping Song

Get full text

P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF PC-002(SEPB)，A FIRST-IN-CLASS INHIBITOR OF DEUBIQUITINASES TARGETI... by Sung-Soo Yoon, Zhiming LI, Keshu Zhou, Xiaoxi Zhou, Ye Guo, Huilai Zhang, Ki-Seong Eom, Seok Jin Kim, Sung Yong Oh, Sungnam Lim, Hagop Youssoufian, Vernon C Jiang, Zanchun Huang, Georgina Kilfoil, Xin Wang, Zhixiang Cao, Xiang LI, Alexander Wu, Yiyou Chen, Yuqin Song

Get full text

PB2272: PI3KΔ INHIBITOR LINPERLISIB FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL by Lihua Qiu, Tingyu Wang, Xiuhua Sun, Hang Su, Junning Cao, Zhi-Ming LI, Yuqin Song, LI Zhang, Dengju LI, Huijing Wu, Wei Zhang, Junmin LI, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng LI, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei LI, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun LI, Shuhua Yi, Lugui Qiu

Get full text

PB2269: PI3KΔ INHIBITOR LINPERLISIB FOR ELDERLY PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL by Xiuhua Sun, Tingyu Wang, Lihua Qiu, Hang Su, Junning Cao, Zhi-Ming LI, Yuqin Song, LI Zhang, Dengju LI, Huijing Wu, Wei Zhang, Junmin LI, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng LI, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei LI, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun LI, Shuhua Yi, Lugui Qiu

Get full text

P1099: A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF PARSACLISIB, A PI3KΔ INHIBITOR, IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA IN CHINA: UPDATED RESULTS FROM THE STUDY by Zhong Zheng, Huilai Zhang, Keshu Zhou, Hui Zhou, LI Zhang, Caixia LI, Min Zhou, Wenbin Qian, Zhiming LI, Qingyuan Zhang, Ying Cheng, Liu Peng, Zhenyu LI, Liping Su, Fei LI, Xiuhua Sun, Jingwen Wang, Yuhuan Gao, Xielan Zhao, Kunyan LI, Kaiyang Ding, Zunmin Zhu, Ying Wang, Hongmei Jing, Xiaohong Xu, Xin Wang, Zimin Sun, Da Gao, Wei-LI Zhao

Get full text

Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201) by Yuqin Song, Keshu Zhou, Chuan Jin, Zhengzi Qian, Ming Hou, Lei Fan, Fei Li, Kaiyang Ding, Hui Zhou, Xiaoling Li, Bing Chen, Xiuhua Sun, Xianmin Song, Ming Jiang, Qingyuan Zhang, Lihong Liu, Guohua Yu, Yu Hu, Zheng Zhao, Ligen Liu, Hongwei Xue, Jun Luo, Bai He, Xiaoping Jin, Min Zhao, Baiyong Li, Yu Xia, Jun Zhu

Get full text